ROUNDTABLE: Flexible Facilities – Strategies for Supplying Complex Biologics in a Changing Global Market

This podcast features:
Susan Dexter, Principal Consultant, Latham Biopharm Group

Geoff Hodge, VP of Biomanufacturing Services, Xcellerex, a GE Healthcare Company
Dr. Abdullah Baaj, Founder and CEO, Boston Oncology
Dr. Yan-Ping Yang, Head of Downstream Processing, Sanofi Pasteur
Peter Cramer, Vice President, M&W Group



This podcast was recorded at the 2013 BioProcess Theater which took place at the 2013 BIO International Convention, April 22-25, 2013. The BioProcess Theater, a 50-seat amphitheater located on the exhibition floor at the heart of the BioProcess Zone, provided attendees with daily, complimentary opportunities to listen, learn, and interact with leading experts as they presented, discussed and debated the latest business and scientific trends impacting the development and manufacture of biotherapeutics.

The 2013 BioProcess Theater consisted of five main presentation tracks: Biosimilars, Single-Use Processing, Cell Therapy, Antibody/Non-Antibody Manufacturing, and Vaccine Manufacturing.

If you would like more information on these presentations, please email us:

Leave a Reply